Rare kidney disease
2025 · 1st Quarter (Jan 1 - Mar 31)
TRAVERE THERAPEUTICS
Filed by THE HEALTH EQUITY STRATEGIES GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- May 6, 2025
- Income
- $16,000.00
- Expenses
- Not reported
- Registrant
- THE HEALTH EQUITY STRATEGIES GROUP, LLC
- Client
- TRAVERE THERAPEUTICS
- Filing UUID
- c6789080-f24b-4b96-9ec4-a2201f044cad
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Rare kidney disease
Rare kidney disease
Rare kidney disease
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.